Clinical trial

Fulvestrant in Hormone Refractory Prostate Cancer

NCT00476645

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-09-01

PhasePHASE2

Study timeline

Study start (unknown)2006-09-01Date precision: month

Registry last updated2014-08-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasmsunresolved

Prostate Cancerunresolved

Interventions

FulvestrantDRUG · verified · RxNorm: fulvestrant

Sponsors & collaborators

Stanford Universitylead sponsor

AstraZenecacollaborator

Mapped research locations

StanfordCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00476645 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.